BILAXTEN cpr orodisp 20 mg 30 pce
7680683810054
CH-68381
R06AX29
07.13.1.
1 / 3
google
Details
- Product number
- 6838101
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- bilastinum 20 mg, mannitolum, carmellosum natricum conexum, natrii stearylis fumaras, sucralosum, aromatica (Rote Trauben) cum ethanolum et geraniolum et linaloolum, pro compresso corresp. natrium 1.022 mg.
Articles (1)
Bilaxten 20 mg, Schmelztabletten
Schmelztabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
1.022 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 11.90
Specialties list
Yes
Generic
No
SL addition date:
01/11/2022
Authorization holder
A. Menarini GmbH
8050 Zürich
Authorization information
- Swissmedic authorization number
- 68381
- Drug name
- Bilaxten, Schmelztabletten
- Galenic form
- SCHM
- ATC Code
- R06AX29
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 15/03/2022
- Authorization expiration date
- 14/03/2027
- IT number
- 07.13.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BILAXTEN cpr orodisp 20 mg 30 pce
- Description (DE)
- BILAXTEN Schmelztabl 20 mg 30 Stk
- Market launch
- 15/03/2022
- Narcotic (BTM)
- No